Thus, through the tumor cell extrinsic and intrinsic functions of PD-L2, VEGFR2 can affect both osteosarcoma cell metastasis and immune escape through the deactivation of STAT3 and the RhoA-ROCK-LIMK2 pathway (Figure 6E). This evidence concerns the gene PDCD1LG2 and osteosarcoma.